TagsEPICS-III Phase 2(B)/3 Trial

Tag: EPICS-III Phase 2(B)/3 Trial

Corporate

Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis

Ravindra Soni - August 29, 2025 0

Most Read

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

TukTuki streams ‘What Is Dyslexia’ film for Dyslexia Awareness Month

November 4, 2026

INOX India Q2 FY27 revenue rises 26.6% to ₹467 crore, order backlog hits record

November 3, 2026

EDITOR PICKS

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

TukTuki streams ‘What Is Dyslexia’ film for Dyslexia Awareness Month

November 4, 2026

POPULAR POSTS

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

TukTuki streams ‘What Is Dyslexia’ film for Dyslexia Awareness Month

November 4, 2026

ABOUT US

BusinessFortnight (businessfortnight.com) is an Indian digital news and media platform that covers business, economy, banking, insurance, real estate, automobiles, aviation, and hospitality news

Contact us: editorbusinessfortnight(@)gmail.com

© BusinessFortnight.com. All Rights Reserved.